InvestorsHub Logo
Followers 15
Posts 238
Boards Moderated 0
Alias Born 10/20/2021

Re: scotty3371 post# 513338

Tuesday, 09/13/2022 5:21:45 AM

Tuesday, September 13, 2022 5:21:45 AM

Post# of 704397
Whose OS is no good? NWBO’s OS results are spectacular and DCVax outperformed the current SOC. If you’re discussing other companies, their results have nothing to do with NWBO. The exceptions would be any company that is involved in combination trials with NWBO. PFS is not an accurate reflection of results, OS is the MOST important indicator of success. We are fortunate that NWBO’s phase 3 trial continued long enough to verify it’s OS success in treatment of nGBM and rGBM with no side affects.

Good luck to patients, NWBO, and the investors who believe in the science and success of the DCVAX platform.

Margaret
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News